Vitamin D deficiency associated with differentiated thyroid carcinoma: A case- control study

Asian Pacific Journal of Cancer Prevention

Volumn 18, Issue 12, 2017, Pages 3419-3422

  Heidari, Zahra ^a   Nikbakht, Mahdi ^a   Mashhadi, Mohammad Ali ^a   Jahantigh, Mahdi ^a   Mansournia, Nasrin ^b   Sheikhi, Vahid ^a   Mansournia, Mohammad Ali ^c  

^a ZAHEDAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b AJA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Etiology; Thyroid cancer; Vitamin D

Indexed keywords

VITAMIN D;

ADULT; BLOOD; CASE CONTROL STUDY; CELL DIFFERENTIATION; COMPLICATION; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; IRAN; MALE; PROGNOSIS; THYROID TUMOR; THYROIDECTOMY; VITAMIN D DEFICIENCY;

ADULT; CASE-CONTROL STUDIES; CELL DIFFERENTIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; IRAN; MALE; PROGNOSIS; THYROID NEOPLASMS; THYROIDECTOMY; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85038915103     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.22034/APJCP.2017.18.12.3419     Document Type: Article

References (36)

1. Abbas S, Linseisen J, Slanger T, et al (2008). Serum 25-hydroxyvitamin D and risk of post-menopausal breast cancer-results of a large case-control study. Carcinogenesis, 29, 93-9
2. Ahonen MH, Tenkanen L, Teppo L, Hakama M, Tuohimaa P (2000). Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland). Cancer Causes Control, 11, 847-52
3. Amphlett B, Lawson Z, Abdulrahman GO, et al (2013). Recent trends in the incidence, geographical distribution, and survival from thyroid cancer in Wales, 1985-2010. Thyroid, 23, 1470-8
4. Biondi B, Arpaia D, Montuori P, et al (2012). Under the shadow of vesuvius: a risk for thyroid cancer?. Thyroid, 22, 1296-7
5. Borena W, Stocks T, Jonsson H, et al (2011). Serum triglycerides and cancer risk in the metabolic syndrome and cancer (Me-Can) collaborative study. Cancer Causes Control, 22, 291-9
6. Clero E, Doyon F, Chungue V, et al (2012). Dietary patterns, goitrogenic food, and thyroid cancer: a case-control study in French Polynesia. Nutr Cancer, 64, 929-36
7. Colonna M, Uhry Z, Guizard AV, et al (2015). Recent trends in incidence, geographical distribution, and survival of papillary thyroid cancer in France. Cancer Epidemiol, 39, 511-8
8. Dal Maso L, Lise M, Zambon P, et al (2011). Incidence of thyroid cancer in Italy, 1991-2005: time trends and age-period-cohort effects. Ann Oncol, 22, 957-63
9. Davies L, Morris LG, Haymart M, et al (2015). American association of clinical endocrinologists and American college of endocrinology disease state clinical review: The increasing incidence of thyroid cancer. Endocr Pract, 21, 686-96
10. Deeb KK, Trump DL, Johnson CS (2007). Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer, 7, 684-700
11. Delshad H, Mehran L, Azizi F (2010). Appropriate iodine nutrition in Iran: 20 years of success. Acta Med Iran, 48, 361-6
12. Dom G, Tarabichi M, Unger K, et al (2012). A gene expression signature distinguishes normal tissues of sporadic and radiation-induced papillary thyroid carcinomas. Br J Cancer, 107, 994-1000
13. Ellison LF, Wilkins K (2012). Canadian trends in cancer prevalence. Health Rep, 23, 7-16
14. Enewold L, Zhu K, Ron E, et al (2009). Rising thyroid cancer incidence in the United States by demographic and tumor characteristics, 1980-2005. Cancer Epidemiol Biomarkers Prev, 18, 784-91
15. Garland CF, Garland FC, Gorham ED, et al (2006). The role of vitamin D in cancer prevention. Am J Public Health, 96, 252-61
16. Giovannucci E (2008). Vitamin D status and cancer incidence and mortality. Adv Exp Med Biol, 624, 31-42
17. Greenland S, Mansournia MA (2015). Penalization, bias reduction, and default priors in logistic and related categorical and survival regressions. Stat Med, 34, 3133-43
18. Greenland S, Mansournia MA, Altman DG (2016). Sparse data bias: a problem hiding in plain sight. BMJ, 352, i1981
19. Haggar FA, Preen DB, Pereira G, Holman CD, Einarsdottir K (2012). Cancer incidence and mortality trends in Australian adolescents and young adults, 1982-2007. BMC Cancer, 12, 151
20. Hansen CM, Binderup L, Hamberg KJ, Carlberg C (2001). Vitamin D and cancer: effects of 1,25(OH)2D3 and its analogs on growth control and tumorigenesis. Front Biosci, 6, 820-48
21. Holick MF (2007). Vitamin D deficiency. N Engl J Med, 357, 266-81
22. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90
23. Jonklaas J, Danielsen M, Wang H (2013). A pilot study of serum selenium, vitamin D, and thyrotropin concentrations in patients with thyroid cancer. Thyroid, 23, 1079-86
24. Jung SK, Kim K, Tae K, Kong G, Kim MK (2013). The effect of raw vegetable and fruit intake on thyroid cancer risk among women: a case-control study in South Korea. Br J Nutr, 109, 118-28
25. Jung KW, Won YJ, Oh CM, et al (2017). Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014. Cancer Res Treat, 49, 292-305
26. Kent WD, Hall SF, Isotalo PA, et al (2007). Increased incidence of differentiated thyroid carcinoma and detection of subclinical disease. CMAJ, 177, 1357-61
27. Laney N, Meza J, Lyden E, et al (2010). The prevalence of vitamin D deficiency is similar between thyroid nodule and thyroid cancer patients. Int J Endocrinol, 2010, 805716
28. Mansournia MA, Hernan MA, Greenland S (2013). Matched designs and causal diagrams. Int J Epidemiol, 42, 860-9
29. Meinhold CL, Ron E, Schonfeld SJ, et al (2010). Nonradiation risk factors for thyroid cancer in the US radiologic technologists study. Am J Epidemiol, 171, 242-52
30. Pellegriti G, De Vathaire F, Scollo C, et al (2009). Papillary thyroid cancer incidence in the volcanic area of Sicily. J Natl Cancer Inst, 101, 1575-83
31. Rapoport B, Chazenbalk GD, Jaume JC, McLachlan SM (1998). The thyrotropin (TSH) receptor: interaction with TSH and autoantibodies. Endocr Rev, 19, 673-716
32. Rezzonico JN, Rezzonico M, Pusiol E, Pitoia F, Niepomniszcze H (2009). Increased prevalence of insulin resistance in patients with differentiated thyroid carcinoma. Metab Syndr Relat Disord, 7, 375-80
33. Roskies M, Dolev Y, Caglar D, et al (2012). Vitamin D deficiency as a potentially modifiable risk factor for thyroid cancer. J Otolaryngol Head Neck Surg, 41, 160-3
34. Stepien T, Krupinski R, Sopinski J, et al (2010). Decreased 1-25 dihydroxyvitamin D3 concentration in peripheral blood serum of patients with thyroid cancer. Arch Med Res, 41, 190-4
35. Tuttle RM, Haddad RI, Ball DW, et al (2014). Thyroid carcinoma, version 2.2014. J Natl Compr Canc Netw, 12, 1671-80
36. Zhao ZG, Guo XG, Ba CX, et al (2012). Overweight, obesity and thyroid cancer risk: a meta-analysis of cohort studies. J Int Med Res, 40, 2041-50